These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8430680)

  • 1. Effect of continuous ambulatory peritoneal dialysis on blood pressure control.
    Saldanha LF; Weiler EW; Gonick HC
    Am J Kidney Dis; 1993 Feb; 21(2):184-8. PubMed ID: 8430680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of hypertension is better during hemodialysis than during continuous ambulatory peritoneal dialysis in ESRD patients.
    Velasquez MT; Lew SQ; von Albertini B; Mishkin GJ; Bosch JP
    Clin Nephrol; 1997 Dec; 48(6):341-5. PubMed ID: 9438091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human erythropoietin dosage in children undergoing hemodialysis and continuous ambulatory peritoneal dialysis.
    Sieniawska M; Roszkowska-Blaim M
    Pediatr Nephrol; 1997 Oct; 11(5):628-30. PubMed ID: 9323294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of anaemia in CAPD patients with recombinant human erythropoietin.
    Ramello A; Malcangi U; Bruno M; Perosa P; Reina E; Rizzuto A; Nasini MG; Carozzi S
    Adv Perit Dial; 1990; 6():308-11. PubMed ID: 1982834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of recombinant human erythropoietin treatment on hemodynamic parameters in continuous ambulatory peritoneal dialysis and hemodialysis patients.
    Fernández A; Vega N; Jiménez F; Macía M; Laraudiogoitía E; Hortal L; Perdomo M; Plaza C; Rodríguez JC; Palop L
    Am J Nephrol; 1992; 12(4):207-11. PubMed ID: 1481867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin in continuous ambulatory peritoneal dialysis: experience with subcutaneous administration.
    Eisele G; Bailie GR; Clement C; Wong E
    Perit Dial Int; 1992; 12(1):34-6. PubMed ID: 1543777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose erythropoietin is effective and safe in children on continuous ambulatory peritoneal dialysis.
    Yalçinkaya F; Tümer N; Cakar N; Ozkaya N
    Pediatr Nephrol; 1997 Jun; 11(3):350-2. PubMed ID: 9203190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialysis efficiency in continuous ambulatory peritoneal dialysis patients treated with erythropoietin.
    Taylor JE; MacTier RA; Henderson IS; Belch JJ; Stewart WK
    Perit Dial Int; 1992; 12(2):221-6. PubMed ID: 1586685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous ferric saccharate as an iron supplement in dialysis patients.
    Silverberg DS; Blum M; Peer G; Kaplan E; Iaina A
    Nephron; 1996; 72(3):413-7. PubMed ID: 8852489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of recombinant erythropoietin on the early hematocrit rise after CAPD initiation.
    Golper TA
    Perit Dial Int; 1992; 12(1):37-9. PubMed ID: 1543778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of erythropoietin on blood pressure in continuous ambulatory peritoneal dialysis patients.
    Balaskas EV; Melamed IR; Gupta A; Bargman J; Oreopoulos DG
    Perit Dial Int; 1993; 13 Suppl 2():S553-7. PubMed ID: 8399663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of erythropoietin in the reversal of anemia of renal failure with continuous ambulatory peritoneal dialysis.
    Chandra M; McVicar M; Clemons G; Mossey RT; Wilkes BM
    Nephron; 1987; 46(3):312-5. PubMed ID: 3627325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group.
    Nissenson AR
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of continuous peritoneal dialysis patients to subcutaneous recombinant human erythropoietin differs from that of hemodialysis patients.
    Besarab A; Golper TA
    ASAIO Trans; 1991; 37(3):M395-6. PubMed ID: 1751205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echocardiographic evaluation in long-term continuous ambulatory peritoneal dialysis compared with the hemodialysis patients.
    Takeda K; Nakamoto M; Baba M; Tanaka T; Yasunaga C; Nishihara G; Matsuo K; Urabe M
    Clin Nephrol; 1998 May; 49(5):308-12. PubMed ID: 9617495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of hematocrit on peritoneal transport.
    Korbet SM; Vonesh EF; Firanek CA
    Am J Kidney Dis; 1991 Nov; 18(5):573-8. PubMed ID: 1951337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction of anemia in patients on continuous ambulatory peritoneal dialysis with subcutaneous recombinant erythropoietin twice a week: a long-term study.
    Cheng IK; Cy C; Chan MK; Yu L; Fang GX; Wei D
    Clin Nephrol; 1991 May; 35(5):207-12. PubMed ID: 1855328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin resistance in patients on continuous ambulatory peritoneal dialysis.
    Nakamoto H; Kanno Y; Okada H; Suzuki H
    Adv Perit Dial; 2004; 20():111-6. PubMed ID: 15384808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infrequent dosing of subcutaneous erythropoietin for the treatment of anemia in patients on CAPD.
    Bunke M; Bartlett DK; Brier ME; Golper TA
    Adv Perit Dial; 1993; 9():331-5. PubMed ID: 8105957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Utilization of EPO in CAPD].
    Ramello A; Perosa P; Bruno M; Reina E; Rizzuto A; Bertasso L; Roggero A; Malcangi U
    Minerva Urol Nefrol; 1991; 43(3):137-41. PubMed ID: 1817335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.